ArticleAmerican journal of ophthalmology case reports2022

Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer.

Matthew G Field et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.